{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:46:18Z","timestamp":1777369578217,"version":"3.51.4"},"reference-count":83,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T00:00:00Z","timestamp":1153180800000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2006,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Resistance to erythropoietin therapy is a common complication of the modern management of anemia in chronic kidney disease. Iron deficiency, deficiency of other nutrients, toxins, infections, and inadequate dialysis account for the vast majority of episodes of such resistance.<\/jats:p>","DOI":"10.1111\/j.1525-139x.2006.00172.x","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T11:04:35Z","timestamp":1284635075000},"page":"273-278","source":"Crossref","is-referenced-by-count":32,"title":["HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Erythropoietin Resistance in the Treatment of the Anemia of Chronic Renal Failure"],"prefix":"10.1111","volume":"19","author":[{"given":"Anumeet","family":"Priyadarshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph I.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,18]]},"reference":[{"issue":"3","key":"e_1_2_23_2_2","first-page":"55","article-title":"Trends in use, cost, and outcomes of human recombinant erythropoietin, 1989\u201398","volume":"20","author":"Greer JW","year":"1999","journal-title":"Health Care Financ Rev"},{"key":"e_1_2_23_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/179633a0"},{"key":"e_1_2_23_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)63387-9"},{"key":"e_1_2_23_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)35756-3"},{"key":"e_1_2_23_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00140.x"},{"key":"e_1_2_23_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000016440.52271.F7"},{"issue":"1","key":"e_1_2_23_8_2","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0272-6386(01)70008-X","article-title":"NKF\u2010DOQI Clinical Practice Guidelines for Anemia of Chronic Renal Failure: update 2000. IV. Administration of epoetin","volume":"37","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_23_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90116-5"},{"key":"e_1_2_23_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(58)90357-7"},{"key":"e_1_2_23_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90546-6"},{"key":"e_1_2_23_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.91"},{"key":"e_1_2_23_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2004.09.005"},{"key":"e_1_2_23_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90649-5"},{"key":"e_1_2_23_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.supp2.69"},{"key":"e_1_2_23_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.supp2.62"},{"key":"e_1_2_23_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90339-5"},{"key":"e_1_2_23_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70259-3"},{"key":"e_1_2_23_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196703232761202"},{"key":"e_1_2_23_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.supp2.96"},{"key":"e_1_2_23_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)92430-8"},{"key":"e_1_2_23_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1989.tb01390.x"},{"key":"e_1_2_23_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365519009089178"},{"key":"e_1_2_23_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000166851"},{"key":"e_1_2_23_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186581"},{"key":"e_1_2_23_26_2","first-page":"27","article-title":"Participation of the renin\u2010angiotensin system in the captopril\u2010induced worsening of anemia in chronic hemodialysis patients","volume":"26","author":"Hirakata H","year":"1986","journal-title":"Clin Nephrol"},{"key":"e_1_2_23_27_2","first-page":"1358","article-title":"ACE inhibitors do not affect erythropoietin efficacy in hemodialysis patients","volume":"9","author":"Conlon PJ","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_23_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90464-3"},{"key":"e_1_2_23_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.12.2316"},{"key":"e_1_2_23_30_2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V29.5.754.754","article-title":"Study of erythroid erythropoietic action of angiotensin II","volume":"29","author":"Nakao K","year":"1967","journal-title":"Blood"},{"key":"e_1_2_23_31_2","first-page":"523","article-title":"Interrelation of the renin system and erythropoietin in rats","volume":"96","author":"Gould AB","year":"1980","journal-title":"J Lab Clin Med"},{"key":"e_1_2_23_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90496-4"},{"key":"e_1_2_23_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1990.tb01928.x"},{"key":"e_1_2_23_34_2","first-page":"280","article-title":"Erythrocytosis after renal transplant study of erythroid progenitors and response to enalapril","volume":"26","author":"Rostaing L","year":"1994","journal-title":"Transplant Proc"},{"key":"e_1_2_23_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011931"},{"key":"e_1_2_23_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199301213280304"},{"key":"e_1_2_23_37_2","doi-asserted-by":"publisher","DOI":"10.3109\/08860228909066949"},{"key":"e_1_2_23_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2736(01)00427-8"},{"key":"e_1_2_23_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(85)80092-5"},{"key":"e_1_2_23_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.5.342"},{"key":"e_1_2_23_41_2","doi-asserted-by":"publisher","DOI":"10.1159\/000417908"},{"key":"e_1_2_23_42_2","doi-asserted-by":"publisher","DOI":"10.1159\/000073439"},{"key":"e_1_2_23_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6605.1017"},{"key":"e_1_2_23_44_2","first-page":"817","article-title":"Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle\u2010cell anaemia and renal failure","volume":"7","author":"Tomson CR","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_23_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199105093241916"},{"key":"e_1_2_23_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110173251614"},{"key":"e_1_2_23_47_2","first-page":"290","article-title":"Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy?","volume":"38","author":"Ono K","year":"1992","journal-title":"Clin Nephrol"},{"key":"e_1_2_23_48_2","doi-asserted-by":"publisher","DOI":"10.1159\/000168443"},{"key":"e_1_2_23_49_2","first-page":"343","article-title":"Is folate and vitamin B12 supplementation necessary in chronic hemodialysis patients with EPO treatment? [letter]","volume":"42","author":"Klemm A","year":"1994","journal-title":"Clin Nephrol"},{"key":"e_1_2_23_50_2","first-page":"176","article-title":"Is erythropoietin treatment safe and effective in myeloma patients receiving hemodialysis?","volume":"40","author":"Caillette A","year":"1993","journal-title":"Clin Nephrol"},{"key":"e_1_2_23_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)80595-5"},{"key":"e_1_2_23_52_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188687"},{"key":"e_1_2_23_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh758"},{"key":"e_1_2_23_54_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V133708"},{"key":"e_1_2_23_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199602153340702"},{"key":"e_1_2_23_56_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.1.111"},{"key":"e_1_2_23_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0894-0959.2004.17202.x"},{"key":"e_1_2_23_58_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005040392"},{"key":"e_1_2_23_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.487"},{"key":"e_1_2_23_60_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045053"},{"key":"e_1_2_23_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90105-1"},{"key":"e_1_2_23_62_2","doi-asserted-by":"publisher","DOI":"10.5414\/CNP57136"},{"key":"e_1_2_23_63_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V113530"},{"key":"e_1_2_23_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90151-5"},{"key":"e_1_2_23_65_2","first-page":"2070","article-title":"Importance of iron supply for erythropoietin therapy","volume":"10","author":"Sunder\u2010Plassmann G","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_23_66_2","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/oxfordjournals.ndt.a027459","article-title":"Regular low\u2010dose intravenous iron therapy improves response to erythropoietin in hemodialysis patients","volume":"11","author":"Taylor JE","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_23_67_2","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1681\/ASN.V94664","article-title":"Intravenous infusion of total dose iron is superior to oral iron in treatment of anemia in peritoneal dialysis patients: a single center comparative study","volume":"9","author":"Ahsan N","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_23_68_2","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1016\/S0021-9258(18)67014-0","article-title":"The effects of ascorbic acid on the intra\u2010 cellular metabolism of iron and ferritin","volume":"261","author":"Bridges KR","year":"1986","journal-title":"J Biol Chem"},{"key":"e_1_2_23_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1971.tb07024.x"},{"key":"e_1_2_23_70_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh260"},{"key":"e_1_2_23_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.185"},{"key":"e_1_2_23_72_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183353"},{"key":"e_1_2_23_73_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-3-344"},{"key":"e_1_2_23_74_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.10.025"},{"key":"e_1_2_23_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00110-0"},{"key":"e_1_2_23_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00114-8"},{"key":"e_1_2_23_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80246-0"},{"key":"e_1_2_23_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90307-3"},{"key":"e_1_2_23_79_2","first-page":"264","article-title":"A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis","volume":"37","author":"Berns JS","year":"1992","journal-title":"Clin Nephrol"},{"key":"e_1_2_23_80_2","doi-asserted-by":"publisher","DOI":"10.1159\/000083891"},{"key":"e_1_2_23_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655999750016113"},{"key":"e_1_2_23_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000131523.17045.56"},{"key":"e_1_2_23_83_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199500252-00016"},{"key":"e_1_2_23_84_2","first-page":"422","article-title":"Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy","volume":"49","author":"Sirken G","year":"2003","journal-title":"ASAIO J"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-139X.2006.00172.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-139X.2006.00172.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T06:15:28Z","timestamp":1697091328000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-139X.2006.00172.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":83,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.1111\/j.1525-139X.2006.00172.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-139x.2006.00172.x","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}